These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33054787)
41. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier. Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944 [TBL] [Abstract][Full Text] [Related]
42. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human. Zhang W; Liu QY; Haqqani AS; Leclerc S; Liu Z; Fauteux F; Baumann E; Delaney CE; Ly D; Star AT; Brunette E; Sodja C; Hewitt M; Sandhu JK; Stanimirovic DB Fluids Barriers CNS; 2020 Jul; 17(1):47. PubMed ID: 32698806 [TBL] [Abstract][Full Text] [Related]
43. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Clark AJ; Davis ME Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563 [TBL] [Abstract][Full Text] [Related]
44. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice. Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739 [TBL] [Abstract][Full Text] [Related]
48. Hyperthermic effect of neurotensin in the rabbit. Vybíral S; Nacházel J; Janský L Pflugers Arch; 1986 Mar; 406(3):312-4. PubMed ID: 3960708 [TBL] [Abstract][Full Text] [Related]
49. Neurotensin induces Fos and Zif268 expression in limbic nuclei of the rat brain. Lambert PD; Ely TD; Gross RE; Kilts CD Neuroscience; 1996 Dec; 75(4):1141-51. PubMed ID: 8938747 [TBL] [Abstract][Full Text] [Related]
50. The anti-tumor activity of a neutralizing nanobody targeting leptin receptor in a mouse model of melanoma. McMurphy T; Xiao R; Magee D; Slater A; Zabeau L; Tavernier J; Cao L PLoS One; 2014; 9(2):e89895. PubMed ID: 24587106 [TBL] [Abstract][Full Text] [Related]
51. Brain iron homeostasis. Moos T Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165 [TBL] [Abstract][Full Text] [Related]
52. Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier. Cabezón I; Manich G; Martín-Venegas R; Camins A; Pelegrí C; Vilaplana J Mol Pharm; 2015 Nov; 12(11):4137-45. PubMed ID: 26440359 [TBL] [Abstract][Full Text] [Related]
57. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics. Bannas P; Hambach J; Koch-Nolte F Front Immunol; 2017; 8():1603. PubMed ID: 29213270 [TBL] [Abstract][Full Text] [Related]
58. Highly potent neurotensin analog that causes hypothermia and antinociception. Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713 [TBL] [Abstract][Full Text] [Related]
59. Differences in the pharmacological actions of intrathecally administered neurotensin and morphine. Martin GE; Naruse T Regul Pept; 1982 Feb; 3(2):97-103. PubMed ID: 6895946 [TBL] [Abstract][Full Text] [Related]